IONIS PHARMACEUTICALS INC
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
Ionis Pharmaceuticals is promising in multiple ways -- but it's not dirt cheap or without risks.
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endpoint; other biotech stocks also declined.
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Ionis Pharmaceuticals wins regulatory clearance for its quarterly injection, Zanvastro, in Alexander disease. Analysts are focused elsewhere.
Ionis Pharmaceuticals Drops Another 9% as Bad News Piles Up
A Phase 3 trial failure has erased a year of gains for Ionis Pharmaceuticals in just days, and the ripple effects are rattling rivals across the RNA and rare-disease biotech space with more catalysts still ahead.
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance
The fair value estimate for Ionis Pharmaceuticals has shifted from US$96.73 to US$100.92, a modest reset that puts fresh numbers around the stock. This move comes during an active period of Street research, with some firms lifting targets and others trimming them, reflecting different views on how to factor pipeline milestones and revenue guidance into valuation work. As you read on, you will see what is driving these updates and how to keep track of the evolving analyst narrative around...
Congressional Trades in $IONS
No disclosed congressional trades found in $IONS.
Insider Trades (Form 4)
Devers Shannon L.
Swayze Eric
BENNETT C FRANK
O'NEIL PATRICK R.
Monia Brett P
Birchler Brian
BENNETT C FRANK
Diaz Allene M.
Key People
Birchler Brian
EVP, Corp and Development Ops
BENNETT C FRANK
EVP, Chief Scientific Officer
Kordasiewicz Holly B
EVP, Chief Development Officer
HERMAN JOAN E
Director
KLEIN JOSEPH
Director
BERTHELSEN SPENCER R
Director
Diaz Allene M
Director
YANG MICHAEL J
Director
Hayden Michael R
Director
LOSCALZO JOSEPH
Director
Baroldi Joseph
EVP, Chief Business Officer
Monia Brett P
Chief Executive Officer
ONEIL PATRICK R
EVP CLO & General Counsel
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
ONEIL PATRICK R
EVP CLO & General Counsel
Swayze Eric
EVP Research
Reikes Peter N
Director
HANTSON LUDWIG
Director
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro